Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. Show more
Location: 1359 Broadway, New York, NY, 10018, United States | Website: https://www.progyny.com | Industry: Healthcare Plans | Sector: Healthcare
Market Cap
2.19B
52 Wk Range
$13.86 - $27.25
Previous Close
$25.40
Open
$25.36
Volume
2,266,875
Day Range
$24.43 - $25.60
Enterprise Value
1.872B
Cash
345.2M
Avg Qtr Burn
N/A
Insider Ownership
7.72%
Institutional Own.
-
Qtr Updated
09/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
